UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Douglas Elliman
DOUG
$162M
| $254K | ﹤0.01% |
65,423
-1,390
| -2% | -$5.54K |
|
2327
HealthStream
HSTM
$840M
| $252K | ﹤0.01% |
10,139
-11,818
| -54% | -$284K |
|
|
DM
2328
DELISTED
Desktop Metal, Inc.
DM
| $251K | ﹤0.01% |
18,492
| – | – |
|
2329
SmartRent
SMRT
$272M
| $250K | ﹤0.01% |
103,070
+22,451
| +28% | +$55.5K |
|
2330
Clarus
CLAR
$143M
| $250K | ﹤0.01% |
31,862
-23,962
| -43% | -$233K |
|
2331
Brown-Forman Class A
BF.A
$13.3B
| $247K | ﹤0.01% |
+3,749
| New | +$256K |
|
2332
AMC Global Media
AMCX
$489M
| $246K | ﹤0.01% |
15,706
| – | – |
|
2333
RLX Technology
RLX
$2.46B
| $244K | ﹤0.01% |
106,300
-1,387,670
| -93% | -$2.46M |
|
|
SPNS
2334
DELISTED
Sapiens International
SPNS
| $244K | ﹤0.01% |
13,207
| – | – |
|
2335
Republic Bancorp
RBCAA
$1.95B
| $244K | ﹤0.01% |
+5,963
| New | +$255K |
|
2336
United Microelectronic
UMC
$46.9B
| $242K | ﹤0.01% |
37,100
+900
| +2% | +$5.96K |
|
2337
MetroCity Bankshares
MCBS
$1.03B
| $242K | ﹤0.01% |
+11,200
| New | +$244K |
|
|
NOTV
2338
DELISTED
Inotiv
NOTV
| $241K | ﹤0.01% |
+48,800
| New | +$607K |
|
2339
F&G Annuities & Life
FG
$3.62B
| $241K | ﹤0.01% |
+12,043
| New | +$245K |
|
2340
SmartFinancial
SMBK
$888M
| $239K | ﹤0.01% |
+8,700
| New | +$244K |
|
|
PAMT
2341
PAMT Corp
PAMT
$297M
| $238K | ﹤0.01% |
+9,200
| New | +$262K |
|
2342
Angi Inc
ANGI
$196M
| $236K | ﹤0.01% |
10,051
| – | – |
|
|
BBBY
2343
DELISTED
Bed Bath & Beyond Inc
BBBY
| $236K | ﹤0.01% |
94,079
+4,268
| +5% | +$16.7K |
|
|
SRNE
2344
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $236K | ﹤0.01% |
266,443
| – | – |
|
2345
World Acceptance Corp
WRLD
$873M
| $236K | ﹤0.01% |
3,580
-2,514
| -41% | -$199K |
|
2346
Inovio Pharmaceuticals
INO
$69M
| $236K | ﹤0.01% |
12,610
-1,389
| -10% | -$31.5K |
|
2347
Vuzix
VUZI
$224M
| $235K | ﹤0.01% |
64,641
-16,665
| -20% | -$76.3K |
|
|
MLNK
2348
DELISTED
MeridianLink
MLNK
| $235K | ﹤0.01% |
17,112
+2,521
| +17% | +$38.9K |
|
2349
America's Car Mart
CRMT
$26.9M
| $234K | ﹤0.01% |
+3,243
| New | +$220K |
|
|
NGMS
2350
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $232K | ﹤0.01% |
+19,000
| New | +$286K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.